Abstract
The objective of this systematic review was to collect modern opinions on general issues of diagnostics and treatment of heart failures
in infants with corrected congenital heart diseases, for the purpose of establishing an up-to-date general treatment profile.
Literature searches were conducted across Medline, Science Direct, Cochrane Library, and eLIBRARY, also analysis of reference lists
was performed. 9047 references were identified in total, of which 747 full-text papers published in the last 5 years were selected.
31 papers in total were further picked over as actually referring to pediatric cardiology practice, regarding general principles of diagnostics and treatment of infants with cardiac failure after correction of congenital heart disease. Furthermore, 33 fundamental and
often-cited studies on the same topic were manually selected. Thus, 64 studies comprised the theoretical basis for treatment profile.
Part 2 is dedicated to the treatment planning system.
References
- TalnerN.S., CarboniM.P. Congestive heart failure. In: Rudolph
C.D., Rudolph A.M., Hostetter M.K. et al. Rudolph's pediatrics.
21st edn. New York: McGraw Hill; 2003.
- Bronicki R.A., Chang A.C. Management of the postoperative
pediatric cardiac surgical patient. Crit. Care Med. 2011; 39 (8):
1974-84.
- De Boode W.-P. Cardiac output monitoring in newborns. Early
Human Development. 2010; 86: 143-8.
- Бокерия Л.А. Лобачева Г.В., Бурова С.А. Легочные гипертензионные кризы у детей с врожденными пороками сердца
и усиленным легочным кровотоком в раннем послеоперационном
периоде. Детские болезни сердца и сосудов.
2008; 4: 34-40.
- Бокерия Л.А., Горбачевский С.В., Школьникова М.А. Легочная
гипертензия у детей. М.: Актелион фармасьютикалз;
2013.
- McMurray J.J.V., Adamopoulos S., Anker S.D., Auricchio A.,
Bohm M., Dickstein K. et al. ESC Guidelines for the diagnosis
and treatment of acute and chronic heart failure. Eur. Heart J.
2012; 33 (14): 1787-847.
- Frobel A.K., Hulpke-Wette M., Schmidt K.G., LaerS. Betablockers
for congestive heart failure in children. Cochrane
Database of Systematic Reviews. 2009; 1; Art. No. CD007037.
- Buchhorn R. Beta-blockers in children with congenital heart
disease before a corrective procedure. Rev. Recent Clin. Trials.
2014; 9 (2): 61-3.
- Tabbutt S., Nicolson S.C., Adamson P.C., Zhang X., Hoffman
M.L., Wells W. et al. The safety, efficacy, and pharmacokinetics
of esmolol for blood pressure control immediately
after repair of coarctation of the aorta in infants and children: a
multicenter, double-blind, randomized trial. J. Thorac.
Cardiovasc. Surg. 2008; 136 (2): 321-8.
- Hsu D.T., Pearson G.D. Advances in heart failure. Heart failure
in children. Part I I : diagnosis, treatment, and future directions.
Circulation. Heart Failure. 2009; 2: 490-8.
- Majure D.T., Greco T., Greco M., Ponschab M., Biondi-
Zoccai G., Zangrillo A. et al. Meta-analysis of randomized
trials of effect of milrinone on mortality in cardiac surgery:
an update. J. Cardiothorac. Vasc. Anesth. 2013; 27 (2):
220-9.
- Hoffman T.M., Wernovsky G., Atz A.M., Kulik T.J.,
Nelson D.P., Chang A.C. et al. Efficacy and safety of milrinone
in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Circulation. 2003; 107 (7): 996-1002.
- Лобачева Г.В., Старовойтов А.А., Харькин А.В., Квасников
Б.Б. Первый опыт применения левосимендана у пациентов
с низким сердечным выбросом после кардиохирургических вмешательств. Детские болезни сердца и сосудов. 2005; 4: 58-64.
- Лобачева Г.В. Сенситизаторы кальция в лечении послеоперационного синдрома низкого сердечного выброса в кардиохирургии. Клиническая физиология кровообращения. 2012; 3: 5-9.
- Hoffman T.M. Newer inotropes in pediatric heart failure.
J. Cardiovasc. Pharmacol 2011; 58 (2): 121-5.
- Angadi U., Westrope C., Chowdhry M.F. Is levosimendan
effective in paediatric heart failure and post-cardiac surgeries?
Interact. Cardiovasc. Thorac. Surg. 2013; 17 (4): 710-4.
- Lechner E., Hofer A., Leitner-Peneder G., Freynschlag R.,
Mair R., Weinzettel R. et al. Levosimendan versus milrinone
in neonates and infants after corrective open-heart surgery:
a pilot study. Pediatr. Crit. Care Med. 2012; 13 (5): 542-8.
- Ricci Z., Garisto C., Favia I., Vitale V., Di Chiara L . , Cogo P.E.
Levosimendan infusion in newborns after corrective surgery
for congenital heart disease: randomized controlled trial.
Intensive Care Med. 2012; 38 (7): 1198-204.
- Colucci W.S., Elkayam U., Horton D.P., Abraham W.T.,
Bourge R.C., Johnson A.D. et al. Intravenous nesiritide, a
natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N. Engl. J. Med.
2000; 343 (4): 246-53.
- Choong K., Kissoon N. Vasopressin in pediatric shock and cardiac arrest. Pediatr. Crit. Care Med. 2008; 9 (4): 372-9.
- Бокерия Л.А., Милиевская Е.Б., Кассирский Г.И., Туманян
М.Р. Организационные вопросы реабилитации пациентов после хирургического лечения врожденных пороков
сердца. Детские болезни сердца и сосудов. 2011; 4:
62-74.
- Кассирский Г.И., Медведева О.И., Ермоленко М.Л., Зотова
Л.М., Неведрова М.Н. Самсонов В.Б. и др. Оценка показателей гемодинамики при физической нагрузке у детей
и подростков в отдаленные сроки после операции протезирования аортального клапана. Детские болезни сердца
и сосудов. 2012; 2: 13-9.
- Maron B.J., Zipes D.P. 36th Bethesda Conference: eligibility
recommendations for competitive athletes with cardiovascular
abnormalities. JACC. 2005; 45: 1312-75.
- Maron B.J., Thompson P.D., Ackerman M.J., Balady G.,
Berger S., Cohen D. et al. AHA Scientific Statements.
Recommendations and considerations related to preparticipatioscreening for cardiovascular abnormalities in competitive athletes: 2007 update. A Scientific statement from the
American Heart Association Council on Nutrition, Physical
Activity, and Metabolism: endorsed by the American College
of Cardiology Foundation. Circulation. 2007; 115: 1643-55.
